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Background:  Evidence suggests that adiponectin is involved in the pathogenesis of atherosclerosis. In the present study we examined the impact 
of T45G polymorphism on adiponectin gene, on the risk for coronary artery disease (CAD) and the expression of adipokines in heathy individuals and 
patients with CAD.
Methods: We studied 214 pts with CAD and 147 healthy controls. Genetic polymorphism T45G was determined by PCR, while circulating 
adiponectin, resistin and leptin levels were determined by ELISA.
Results: The genotype distribution was different between CAD patients (GG: 5(2.3%) GT: 65(30.4%), TT:144(67.3%)) and controls (GG:2(1.4%), 
GT: 31(21.1%), TT:114(77.6%), p<0.05). The risk for CAD was OR[95%CI]:0.595[0.368-0.964], p=0.03 for 45TT vs 45GT+GG. Importantly, The 45TT 
homozygotes had lower risk of arterial hypertension (OR[95%CI]:0.439[0.270-0.713], p=0.001). The 45TT genotype was associated with higher 
adiponectin levels (13.1±1.14mcg/ml) compared to 45GT+GG (8.30±2.17mcg/ml, p<0.05) among healthy individuals, but not in CAD patients 
(13.67±0.97 vs 15.20±1.6mcg/ml respectively, p=NS). Circulating resistin and leptin were not different between genotypes in the control group 
(6.88±0.40 and 13.6±0.85 in TT vs 6.16±0.65 pg/ml and 14.04±2.23 pg/ml in GT+GG, p=NS for both). In the CAD group, leptin levels were also 
similar between 45TT (15.2±1.8pg/ml) and 45GT+GG (14.1±3.2pg/ml, p=NS). Similarly, the 45TT genotype had similar resistin (5.9±0.3pg/ml) 
compared to 45GT+GG (7.69±0.81pg/ml, p=NS), in the CAD group.
Conclusions: The findings of the present study indicate that the 45TT genotype of adiponectin gene is associated with lower risk of arterial 
hypertension and decreased cardiovascular risk. This genotype has a striking effect on adiponectin expression in healthy individuals, but not in CAD 
patients. Therefore, homozygosity for the 45T allele decreases the risk for CAD by increasing circulating levels of adiponectin in healthy individuals, 
while its functional effect is masked after the establishment of coronary atherosclerosis.
